Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19568080 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Two-Part Study of BOTOX® Therapy for Ischemic Digits
Condition: Raynaud's Disease
Intervention: Drug: onabotulinum toxin type-A
2 Not yet recruiting Botulinum Toxin Type A for Neuroma Pain
Condition: Neuroma
Interventions: Drug: onabotulinum toxin type-A;   Other: placebo;   Drug: 2nd phase - onabotulinum toxin type-A

Indicates status has not been verified in more than two years